Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies
- PMID: 32508193
- DOI: 10.1080/13685538.2020.1774748
Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies
Abstract
Purpose: Coronavirus disease 2019 (COVID-19) is an emerging disease that was first reported in Wuhan city, the capital of Hubei province in China, and has subsequently spread worldwide. Risk factors for mortality have not been well summarized. Current meta-analysis of retrospective cohort studies was done to summarize available findings on the association between age, gender, comorbidities and risk of death from COVID-19 infection.
Methods: Online databases including Web of Science, PubMed, Scopus, Cochrane Library and Google scholar were searched to detect relevant publications up to 1 May 2020, using relevant keywords. To pool data, random-effects model was used. Furthermore, sensitivity analysis and publication bias test were also done.
Results: In total, 14 studies with 29,909 COVID-19 infected patients and 1445 cases of death were included in the current meta-analysis. Significant associations were found between older age (≥65 vs <65 years old) (pooled ORs = 4.59, 95%CIs = 2.61-8.04, p < .001), gender (male vs female) (pooled ORs = 1.50, 95%CIs = 1.06-2.12, p = .021) and risk of death from COVID-19 infection. In addition, hypertension (pooled ORs = 2.70, 95%CIs = 1.40-5.24, p = .003), cardiovascular diseases (CVDs) (pooled ORs = 3.72, 95%CIs = 1.77-7.83, p = .001), diabetes (pooled ORs = 2.41, 95%CIs = 1.05-5.51, p = .037), chronic obstructive pulmonary disease (COPD) (pooled ORs = 3.53, 95%CIs = 1.79-6.96, p < .001) and cancer (pooled ORs = 3.04, 95%CIs = 1.80-5.14, p < .001), were associated with higher risk of mortality.
Conclusions: Older age (≥65 years old), male gender, hypertension, CVDs, diabetes, COPD and malignancies were associated with greater risk of death from COVID-19 infection. These findings could help clinicians to identify patients with poor prognosis at an early stage.
Keywords: COVID-19; SARS-CoV-2; meta-analysis; mortality; systematic review.
Comment in
-
Comment on the review entitled "Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies".Aging Male. 2020 Dec;23(5):1527. doi: 10.1080/13685538.2020.1825667. Epub 2020 Oct 5. Aging Male. 2020. PMID: 33016165 No abstract available.
Similar articles
-
Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients.BMC Infect Dis. 2021 Aug 21;21(1):855. doi: 10.1186/s12879-021-06536-3. BMC Infect Dis. 2021. PMID: 34418980 Free PMC article.
-
Clinical risk factors for mortality of hospitalized patients with COVID-19: systematic review and meta-analysis.Ann Palliat Med. 2021 Mar;10(3):2723-2735. doi: 10.21037/apm-20-1278. Epub 2021 Feb 1. Ann Palliat Med. 2021. PMID: 33549005
-
Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis.J Community Health. 2020 Dec;45(6):1270-1282. doi: 10.1007/s10900-020-00920-x. J Community Health. 2020. PMID: 32918645 Free PMC article.
-
Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients.BMC Cardiovasc Disord. 2021 Jan 7;21(1):23. doi: 10.1186/s12872-020-01816-3. BMC Cardiovasc Disord. 2021. PMID: 33413093 Free PMC article.
-
Risk factors for mortality in COVID-19 patients in sub-Saharan Africa: A systematic review and meta-analysis.PLoS One. 2022 Oct 17;17(10):e0276008. doi: 10.1371/journal.pone.0276008. eCollection 2022. PLoS One. 2022. PMID: 36251715 Free PMC article.
Cited by
-
No significant increase in Guillain-Barré syndrome after COVID-19 vaccination in adults: A vaccine adverse event reporting system study.Vaccine. 2022 Sep 22;40(40):5791-5797. doi: 10.1016/j.vaccine.2022.08.038. Epub 2022 Aug 22. Vaccine. 2022. PMID: 36055875 Free PMC article.
-
Ambulatory Status at Discharge Predicts Six-Month Mortality in Patients with COVID-19: A Retrospective Cohort Study.J Clin Med. 2024 Feb 17;13(4):1129. doi: 10.3390/jcm13041129. J Clin Med. 2024. PMID: 38398442 Free PMC article.
-
Postintubation Decline in Oxygen Saturation Index Predicts Mortality in COVID-19: A Retrospective Pilot Study.Crit Care Res Pract. 2021 May 26;2021:6682944. doi: 10.1155/2021/6682944. eCollection 2021. Crit Care Res Pract. 2021. PMID: 34136282 Free PMC article.
-
Endothelial biomarkers (Von willebrand factor, BDCA3, urokinase) as predictors of mortality in COVID-19 patients: cohort study.BMC Pulm Med. 2024 Jul 4;24(1):325. doi: 10.1186/s12890-024-03136-0. BMC Pulm Med. 2024. PMID: 38965511 Free PMC article.
-
Evaluation of the efficacy and safety of nirmatrelvir/ritonavir co-administration inpatients with rheumatic disease infected with SARS-CoV-2: a real-world study.Front Pharmacol. 2023 Dec 6;14:1288402. doi: 10.3389/fphar.2023.1288402. eCollection 2023. Front Pharmacol. 2023. PMID: 38125894 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous